ATRA Market Cap History
Below is a table of the ATRA market cap history going back to 11/7/2014:

Date ATRA Market Cap
11/7/2014581.12M
2/18/2015489.15M
4/30/20151.01B
7/31/20151.60B
10/31/2015737.82M
2/15/2016442.15M
4/29/2016517.69M
7/31/2016691.46M
10/31/2016369.42M
2/15/2017468.35M
4/30/2017497.77M
7/31/2017466.03M
10/31/2017434.46M
2/15/20181.83B
4/30/20181.77B
7/27/20181.67B
10/31/20181.56B
2/15/20191.87B
4/30/20191.56B
7/31/2019767.13M
10/31/2019591.32M
2/18/2020852.51M
4/30/2020488.71M
7/31/2020920.67M

Also see: ATRA Shares Outstanding History
and ATRA YTD Return
ATRA Historical Market Cap:
+8.36% CAGR
ATRA Historical Market Cap: +8.36% CAGR

Mouse over chart for data details
11/7/2014 ...7/31/2020
Atara Biotherapeutics is an off-the-shelf, allogeneic T-cell immunotherapy company that is developing treatments for patients with cancer, autoimmune and viral diseases. Co.'s primary T-cell immunotherapy, tab-cel® (tabelecleucel), is in development for patients with Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disease who have failed rituximab or rituximab plus chemotherapy, and other EBV-associated hematologic malignancies and solid tumors. Co.'s T-cell immunotherapies in clinical development include ATA188: T-cell immunotherapies targeting EBV antigens for the treatment of multiple sclerosis; and ATA2271/ATA3271: CAR T immunotherapy targeting mesothelin. We show 24 historical shares outstanding datapoints in our ATRA shares outstanding history coverage, used to compute ATRA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ATRA market cap history over the course of time is important for investors interested in comparing ATRA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ATRA versus a peer is one thing; comparing ATRA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ATRA can fluctuate over the course of history. With this page we aim to empower investors researching ATRA by allowing them to research the ATRA market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ATRA:
ATRA SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Atara Biotherapeutics (ATRA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ATRC Market Cap History
ATRI Market Cap History
ATRS Market Cap History
ATXI Market Cap History
AVEO Market Cap History
AVGR Market Cap History
AVXL Market Cap History
AXDX Market Cap History
AXGN Market Cap History
AXSM Market Cap History
More Healthcare companies »

 

ATRA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.